AU1770901A - Combination therapy for lowering and controlling intraocular pressure - Google Patents

Combination therapy for lowering and controlling intraocular pressure

Info

Publication number
AU1770901A
AU1770901A AU1770901A AU1770901A AU1770901A AU 1770901 A AU1770901 A AU 1770901A AU 1770901 A AU1770901 A AU 1770901A AU 1770901 A AU1770901 A AU 1770901A AU 1770901 A AU1770901 A AU 1770901A
Authority
AU
Australia
Prior art keywords
lowering
combination therapy
intraocular pressure
controlling intraocular
controlling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU1770901A
Inventor
Abbot F Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU1770901A publication Critical patent/AU1770901A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU1770901A 2000-11-16 2000-11-16 Combination therapy for lowering and controlling intraocular pressure Pending AU1770901A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/031557 WO2002040030A1 (en) 2000-11-16 2000-11-16 Combination therapy for lowering and controlling intraocular pressure

Publications (1)

Publication Number Publication Date
AU1770901A true AU1770901A (en) 2002-05-27

Family

ID=21742004

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1770901A Pending AU1770901A (en) 2000-11-16 2000-11-16 Combination therapy for lowering and controlling intraocular pressure
AU2001217709A Ceased AU2001217709B2 (en) 2000-11-16 2000-11-16 Combination therapy for lowering and controlling intraocular pressure

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001217709A Ceased AU2001217709B2 (en) 2000-11-16 2000-11-16 Combination therapy for lowering and controlling intraocular pressure

Country Status (5)

Country Link
EP (1) EP1341541A4 (en)
JP (1) JP2004522711A (en)
AU (2) AU1770901A (en)
CA (1) CA2428799A1 (en)
WO (1) WO2002040030A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
US7579335B2 (en) 2005-01-10 2009-08-25 Glaxo Group Limited Androstane 17α-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
EP3006453A1 (en) 2014-10-08 2016-04-13 Cosmo Technologies Ltd. 17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors
CN108066283B (en) * 2017-12-28 2020-03-24 兆科（广州）眼科药物有限公司 Preparation method of levobetaxolol hydrochloride eye drops

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US4904649A (en) * 1986-05-23 1990-02-27 New England Medical Center Hospitals, Inc. Method and solution for treating glaucoma
WO1987007141A1 (en) * 1986-05-23 1987-12-03 New England Medical Center Hospitals, Inc. Method for treating glaucoma
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
US5371078A (en) * 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
US5153193A (en) * 1991-10-01 1992-10-06 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
EP1236471A3 (en) * 1991-11-22 2004-12-15 Alcon Laboratories, Inc. Angiostatic steroids
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
DK1069913T3 (en) * 1998-04-07 2003-11-17 Alcon Mfg Ltd Gelatinization of ophthalmic compositions containing xanthan gum
US6486208B1 (en) * 1998-09-25 2002-11-26 Alcon Laboratories, Inc. Sustained release, and comfortable opthalmic composition and method for ocular therapy

Also Published As

Publication number Publication date
EP1341541A1 (en) 2003-09-10
WO2002040030A1 (en) 2002-05-23
CA2428799A1 (en) 2002-05-23
AU2001217709B2 (en) 2005-10-13
JP2004522711A (en) 2004-07-29
EP1341541A4 (en) 2004-11-17
WO2002040030A8 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
DE60141136D1 (en) Selektive photocoagulation
AU2002229013A1 (en) Improved pressure controller and method
AU2003279005A8 (en) Implantable pressure attenuation device
AU2002220268A1 (en) Anti-drawback medical valve
GB0028429D0 (en) Therapy
GB9914648D0 (en) Control of infra-ocular pressure
GB9925013D0 (en) Pressure relief valve
AU2001222215A1 (en) Lumbago treating girdle
AU1770901A (en) Combination therapy for lowering and controlling intraocular pressure
GB2346178B (en) Integral pump and control valve
AU9038401A (en) Relief valve
GB9919943D0 (en) Control valve unit
AU2001284496A1 (en) Insulin secretion controlling agents
CZ150299A3 (en) Tensometric pressure reducing valve
AU4707900A (en) Methods for controlling intraocular pressure
TW486041U (en) Hydraulic constant pressure controller
TW433555U (en) Safety relief valve
GB0008299D0 (en) Pressure relief valve
AU144530S (en) Manual therapy aid
AU6884801A (en) Therapeutic compounds and methods
GB0031850D0 (en) Hydraulic controller
GB9914814D0 (en) Controlling tyre pressure
PL334262A1 (en) Regulating valve
TW395472U (en) Constant pressure type pressure control valve
GB0014133D0 (en) Combination therapy